Colorectal cancer Posts on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

Robotic rectal cancer surgery offers better recovery of the urogenital organs

Posted by on Apr 14, 2017 in Colorectal cancer | 0 comments

In a nutshell This study compared the functional outcomes of the urinary and sexual organs after a robotic (RRS) or laparoscopic rectal cancer surgery (LRS). Researchers suggested that the robotic rectal surgery offers better post-surgery recovery of these organs. Some background Rectal cancer surgery is associated with a high risk of urinary and...

Read More

Lymph node ratio as a risk factor of recurrence in stage 3 colorectal cancer

Posted by on Apr 14, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the prognostic role of the lymph node ratio (LNR; number of lymph node metastasis per lymph nodes removed) in stage 3 colorectal cancer following post-surgery chemotherapy. Researchers suggested that LNR is strongly associated with recurrence risk (when the cancer comes back) in these patients.  Some...

Read More

Chemotherapy after rectal cancer surgery is associated with improved survival

Posted by on Mar 13, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether chemotherapy after rectal surgery improves survival of rectal cancer patients. Researchers suggested that chemotherapy after rectal surgery is associated with improved survival.  Some background Rectal cancer affects almost 40,000 people annually in the United States. Roughly 50% of these patients...

Read More

Neutropenia is associated with improved survival of colorectal cancer patients treated with TAS-102

Posted by on Mar 13, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether neutropenia (NTP; loss of white blood cells) is related to improved survival in colorectal cancer patients treated with TAS-102. Researchers suggested that patients who experience NTP after one month of treatment have an improved overall survival.  Some background Chemotherapy is used to treat...

Read More

Physical exercise after surgery is associated with improved recovery from colorectal cancer

Posted by on Mar 4, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of exercise on recovery from colorectal cancer surgery. Researchers reported that exercise was associated with an improved recovery. Some background Recovery after surgery is only complete when the patient is able to return to normal day-to-day life. Not all colorectal cancer patients recover their...

Read More

Comparing the safety of surgery options for patients with peritoneal metastasis

Posted by on Jan 11, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the safety of hyperthermic intraperitoneal chemotherapy (HIPEC) and surgery in colon cancer patients with peritoneal metastasis (PM). Researchers reported that HIPEC and surgery was associated with an increased risk of complications. Some background When colon cancer spreads to the abdominal lining (known as...

Read More

Surgery alone may not be enough in rectal cancer: Chemotherapy and radiation are associated with improved outcomes

Posted by on Dec 19, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of stage 3 rectal cancer patients with lymph node metastasis (cancer spread) who did not undergo chemotherapy and radiation (CRT) before surgery. Researchers suggested that these patients have worse outcomes when compared to patients who have undergone CRT.  Some background CRT followed by...

Read More

Panitumumab is associated with improved survival in metastatic colorectal cancer without KRAS or RAS mutations

Posted by on Dec 19, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of panitumumab (Vectibix) in overall survival of patients with metastatic colorectal cancer without a KRAS or RAS mutation. Researchers suggested that panitumumab significantly improved survival in these patients.  Some background Panitumumab is a therapy that targets a...

Read More

Effective and safe neoadjuvant therapy to treat locally advanced rectal cancer

Posted by on Dec 12, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of pre-surgery combined chemotherapy with 5-fluorouracil and oxaliplatin (5-FU/OX) and radiotherapy in locally advanced rectal cancer (LARC). Researchers suggested that this combined treatment could be beneficial for LARC patients.   Some background The standard treatment for...

Read More